Literature DB >> 10101814

Headmaster collar restricts rheumatoid atlantoaxial subluxation.

M Kauppi1, M H Neva, H Kautiainen.   

Abstract

STUDY
DESIGN: A radiographic study of the effect of a modern orthotic device in the treatment of rheumatoid atlantoaxial subluxation.
OBJECTIVE: To study the ability of a new open-type collar to restrict atlantoaxial subluxation. SUMMARY OF BACKGROUND DATA: Atlantoaxial subluxation is common in rheumatoid arthritis, and thus, the development of conservative treatments is important. It has been shown that a custom-made stiff collar significantly restricts atlantoaxial subluxation in approximately half of patients with unstable atlantoaxial subluxation.
METHODS: In 30 successive patients with rheumatoid atlantoaxial subluxation, lateral view radiographs were taken in flexion, extension, and neutral positions without a collar and in flexion with the Headmaster collar.
RESULTS: The mean atlantoaxial distance during flexion was 7.1 +/- 1.8 mm and during extension was 1.0 +/- 1.0 mm, and the mean instability was 6.1 +/- 2.3 mm. In the 20 cases with the greatest stabilizing effect, the mean atlantoaxial distance during flexion with a collar was 1.1 +/- 1.3 mm, whereas in 10 patients with lesser effect it was 6.7 +/- 2.5 mm (P < 0.0001). The lesser stabilizing effect was associated with the presence of atlantoaxial subluxation in the neutral position.
CONCLUSION: The Headmaster collar is an effective and useful tool in the conservative treatment of simple unstable atlantoaxial subluxation, but an ordinary custom-made stiff collar is still often needed. These two collars are complementary, and their selection and use must be determined individually.

Entities:  

Mesh:

Year:  1999        PMID: 10101814     DOI: 10.1097/00007632-199903150-00004

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  2 in total

Review 1.  [Orthoses and assistive devices in rheumatology : Prevention of disability, support of residual function].

Authors:  T Fikentscher; H R Springorum; J Grifka; J Götz
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

Review 2.  [Therapy of cervical rheumatoid arthritis].

Authors:  R Kothe; L Wiesner; W Rüther
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.